New York, United States, 2023-Oct-10 — /EPR Network/ — “According to the research report, the global Hemato Oncology Testing Market was estimated at USD 2,108.69 [read full… Read More
Buy Now
As the elderly population in United States increases, along with an increasing need for early diagnosis & treatment, the esoteric testing is poised to record remarkable growth in… Read More
Decreased vision testing in primary care and in school settings drove an age-related overall decline in vision testing among adolescents, a review of national data showed.
Data from 2018-2… Read More
MADRID — Results from a pair of international phase III trials testing two distinct treatment strategies will usher in new standards of care for women with newly diagnosed, locally… Read More
Radiopharmaceuticals are an emerging and promising approach for diagnosing and treating various types of cancer. Radiopharmaceutical therapy (RPT) has demonstrated effectiveness with minimal… Read More
Pandemic times have taught us the most important lessons of our lives – Healthcare must be our topmost priority. The times have also brought back into focus the criticality of an adage… Read More
Being named a “Top Doc” in San Diego Magazine’s annual “Physicians of Exceptional Excellence” survey is a coveted honor among physicians across the county. Th… Read More
Innovation in digital technologies in the past decade has enabled the definition and inclusion of digital endpoints in clinical trials of various therapeutic areas, including central nervous… Read More
According to the latest research report, the demand of global Virtual Clinical Trials Market size & share was valued at approximately USD 5.37476 Billion in 2019 and is expected to reac… Read More
Custom AI Solutions stand at the forefront of innovation, reshaping industries and redefining possibilities. Leveraging the power of Artificial Intelligence (AI), businesses and organization… Read More
Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Myriad Genetics Inc (
MYGN, Financial). The sto… Read More
October is generally the month that "awareness" around breast cancer research peaks, but it's important to be aware of potentially life-saving screenings and treatments all year long. In gen… Read More